D. W. Harris

发表

Mass Spectral Characterization of an Endogenous Digitalislike Factor From Human Plasma

M. A. Clark, W. Mathews, F. Mandel, 1991, Hypertension.

Development of a high-volume in situ mRNA hybridization assay for the quantification of gene expression utilizing scintillating microplates.

D. Jones, M. Kenrick, D. W. Harris, 1996, Analytical biochemistry.

Effect of norepinephrine uptake blocker on beta-adrenergic receptors of the rat cerebral cortex.

V. Sethy, D. W. Harris, 1981, European journal of pharmacology.

Purification of an Endogenous Digitalislike Factor From Human Plasma for Structural Analysis

M. A. Clark, W. Mathews, F. Mandel, 1991, Hypertension.

Isolation and Characterization of a Sodium Pump Inhibitor From Human Plasma

M. A. Clark, R. White, J. Hamlyn, 1989, Hypertension.

Effects of an Endogenous Ouabainlike Compound on Heart and Aorta

M. Blaustein, S. Bova, J. Hamlyn, 1991, Hypertension.

Synthesis of CDP-diglyceride from phosphatidylinositol and CMP.

K. Sadeghian, D. W. Harris, M. Hokin-Neaverson, 1977, Biochemical and biophysical research communications.

Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.

M. Piercey, R. Mccall, M. Bienkowski, 1994, The Journal of pharmacology and experimental therapeutics.

Development of a Sensitive Activity Assay for High-Volume Evaluation of Human Renin Inhibitory Peptides in Rat Serum: Results with U-71,038

Satish K. Sharma, B. Rush, J. M. Friis, 1990, Pharmaceutical Research.

Development of an Immunoassay for Endogenous Digitalislike Factor

J. Fisher, J. Hamlyn, D. Ducharme, 1991, Hypertension.

Stimulation of cyclic GMP formation in smooth muscle cells by atriopeptin II.

D. W. Harris, G. Johnson, C. A. Baker, 1985, Life sciences.

Determination of biological activity of alprazolam, triazolam and their metabolites

V. Sethy, D. W. Harris, Vimala H. Sethy, 1982, The Journal of pharmacy and pharmacology.

Role of beta‐adrenergic receptors in the mechanism of action of second‐generation antidepressants

V. Sethy, D. W. Harris, 1982 .

Laboratory Studies An Orally Active Inhibitor of Renin

W. Kati, G. Degraaf, D. W. Harris, 2005 .

Identification and characterization of a ouabain-like compound from human plasma.

M. Blaustein, W. Mathews, F. Mandel, 1991, Proceedings of the National Academy of Sciences of the United States of America.

An orally active inhibitor of renin.

W. Kati, S. Thaisrivongs, G. Degraaf, 1986, Hypertension.

Discovery and Characterization of QPT-1, the Progenitor of a New Class of Bacterial Topoisomerase Inhibitors

G. Bammert, A. Hromockyj, K. Marotti, 2008, Antimicrobial Agents and Chemotherapy.

(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.

R. Lahti, M. Smith, S A Rees, 1996, Journal of medicinal chemistry.

Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.

M. Piercey, R. Mccall, K. Merchant, 1996, The Journal of pharmacology and experimental therapeutics.

α-Methylproline-Containing Renin Inhibitory Peptides: In vivo Evaluation in an Anesthetized, Ganglion-Blocked, Hog Renin Infused Rat Model.

S. Thaisrivongs, D. W. Harris, S. R. Turner, 1987 .

alpha-Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion-blocked, hog renin infused rat model.

S. Thaisrivongs, D. W. Harris, S. R. Turner, 1987, Journal of medicinal chemistry.

Effect of chronic antidepressant treatment on α2‐adrenoreceptors

V. Sethy, D. W. Harris, Vimala H. Sethy, 1983 .

Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo.

W. Kati, S. Thaisrivongs, D. W. Harris, 1986, Journal of medicinal chemistry.

Comparative analysis of the feline immunoglobulin repertoire.

G. Ippolito, J. Glanville, S. Steiniger, 2017, Biologicals : journal of the International Association of Biological Standardization.

Discovery and Characterization of QPT-1, the Progenitor of a New Class of Bacterial Topoisomerase Inhibitors (cid:1) †

G. Bammert, A. Hromockyj, K. Marotti, 2008 .

Digitalis-like activity in human plasma. Purification, affinity, and mechanism.

J. Hamlyn, D. W. Harris, J. H. Ludens, 1989, The Journal of biological chemistry.

THE MECHANISM OF STIMULATED PHOSPHATIDYLINOSITOL BREAKDOWN

K. Sadeghian, D. W. Harris, M. Hokin-Neaverson, 1978 .

Effects of an endogenous ouabain-like compound (OLC) on heart and aorta

S. Bova, J. Hamlyn, D. Ducharme, 1991 .

Benzodiazepine receptor number after acute administration of alprazolam and diazepam.

V. Sethy, D. W. Harris, 1982, Research communications in chemical pathology and pharmacology.

High affinity binding of [3H]ethylketocyclazocine to rat brain homogenate.

V. Sethy, D. W. Harris, 1980, European journal of pharmacology.

Renin inhibitors containing psi[CH2O] pseudopeptide inserts.

D. W. Harris, G. Johnson, R E TenBrink, 1988, Journal of medicinal chemistry.

1-(alkylamino)isochromans: hypotensives with peripheral and central activities.

R. Mccall, J. Mccall, C. Daenzer, 1982, Journal of medicinal chemistry.